Schwaneke Jeffrey A.'s Form 4 filing
agilon health, inc. (AGL) · filed Nov 30, 2023
- Accession no.
- 0001628280-23-040361
- Filed
- Nov 30, 2023
- Trade date
- Nov 29, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $250.2K. It was filed 1 day after the trade.
This filing was later replaced by the amendment 0001628280-25-016684 (Apr 3, 2025). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schwaneke Jeffrey A.CIK 0001446919 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2023 | Common Stock | PPurchaseAcquired | +22,300 | $11.22 | +$250,206 | 31,931 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.